Literature DB >> 14734222

Association of loss of 1p and alterations of chromosome 14 in meningioma progression.

Concha Lopez-Gines1, Miguel Cerda-Nicolas, Rosario Gil-Benso, Robert Callaghan, Maria Collado, Pedro Roldan, Antonio Llombart-Bosch.   

Abstract

Meningiomas are usually benign tumors; however, they can recur after surgical resection and occasionally show histologic progression to a higher grade II and III malignancy. The second most frequently reported genetic abnormality after 22q loss is deletion of 1p, although alterations in 9q, 10q, and 14q are also implicated in meningioma progression. Fourteen tumors comprising six benign, four atypical, and four malignant meningiomas were examined by means of cytogenetic and fluorescence in situ hybridization analysis. All tumors showed losses in different regions of 1p, with 1p11, 1p13, 1p21, 1p22, 1p32, and 1q21 breakpoints; eight tumors also presented alterations of chromosome 14. Five of the six cases with deletions on 1p and normal chromosome 14 were grade I, and two were recurrent. All but one of the eight cases with simultaneous 1p deletion and alterations of chromosome 14 were grade II (3 cases) and grade III (4 cases); all the grade III cases were recurrent. These results support the possible association between changes in 1p and chromosome 14 with the evolution of aggressive meningiomas through tumor progression.

Entities:  

Mesh:

Year:  2004        PMID: 14734222     DOI: 10.1016/s0165-4608(03)00279-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  9 in total

1.  TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.

Authors:  Annamaria Biczok; Theo Kraus; Bogdana Suchorska; Nicole A Terpolilli; Jun Thorsteinsdottir; Armin Giese; Joerg C Tonn; Christian Schichor
Journal:  J Neurooncol       Date:  2018-05-28       Impact factor: 4.130

Review 2.  Iodothyronine deiodinases and cancer.

Authors:  A Piekiełko-Witkowska; A Nauman
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

3.  Molecular progression in unusual recurrent non-pediatric intracranial clear cell meningioma.

Authors:  B Domingo-Arrué; R Gil-Benso; J Megías; L Navarro; T San-Miguel; L Muñoz-Hidalgo; C López-Ginés; M Cerdá-Nicolás
Journal:  Curr Oncol       Date:  2017-06-27       Impact factor: 3.677

4.  Chromosome 1p36 and 22qter deletions in paraffin block sections of intracranial meningiomas.

Authors:  Zerrin Yilmaz; Feride Iffet Sahin; Basar Atalay; Ozlem Ozen; Hakan Caner; Murad Bavbek; Beyhan Demirhan; Nur Altinörs
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

5.  Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone.

Authors:  Angel Maillo; Alberto Orfao; Ana B Espinosa; José María Sayagués; Marta Merino; Pablo Sousa; Monica Lara; María Dolores Tabernero
Journal:  Neuro Oncol       Date:  2007-08-17       Impact factor: 12.300

6.  DNA microarray analysis identifies CKS2 and LEPR as potential markers of meningioma recurrence.

Authors:  Francesca Menghi; Francesca N Orzan; Marica Eoli; Mariangela Farinotti; Emanuela Maderna; Federica Pisati; Donatella Bianchessi; Lorella Valletta; Sandro Lodrini; Giuseppe Galli; Elena Anghileri; Serena Pellegatta; Bianca Pollo; Gaetano Finocchiaro
Journal:  Oncologist       Date:  2011-09-23

Review 7.  Emerging glioneuronal and neuronal tumors: case-based review.

Authors:  So Dug Lim; Seong Ik Kim; Jin Woo Park; Jae Kyung Won; Seung-Ki Kim; Ji Hoon Phi; Chun-Kee Chung; Seung-Hong Choi; Hongseok Yun; Sung-Hye Park
Journal:  Brain Tumor Pathol       Date:  2022-01-20       Impact factor: 3.298

8.  Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression.

Authors:  Teresa San-Miguel; Javier Megías; Daniel Monleón; Lara Navarro; Lisandra Muñoz-Hidalgo; Carmina Montoliu; Marina Meri; Pedro Roldán; Miguel Cerdá-Nicolás; Concha López-Ginés
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

9.  Gene expression profiles of metabolic aggressiveness and tumor recurrence in benign meningioma.

Authors:  Eva Serna; José Manuel Morales; Manuel Mata; José Gonzalez-Darder; Teresa San Miguel; Rosario Gil-Benso; Concha Lopez-Gines; Miguel Cerda-Nicolas; Daniel Monleon
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.